In the News

National Cardiovascular Partners (NCP) is the pioneer of the Hybrid Cardiovascular Center model (ASC & Catheterization Lab). Learn how they have successfully partnered with top physicians who are interested in having more professional control and the freedom to provide high-quality patient care.

It’s not hyperbole to say that in the past few years, the healthcare industry has undergone seismic shifts. As the population ages and Americans continue to live longer, the strains on the current system are likely to increase significantly. The urgency of reforming healthcare has become a political hot button as members of Congress debate on how to rein in the costs of what has become the most expensive healthcare system in the world.

Nowhere is this more evident than in the surgical outpatient arena. Advances in technology and more sophisticated surgical procedures have emboldened patients to demand more convenient and cost-effective care. As a result, hospital admissions have steadily declined, and ambulatory surgery centers (ASCs) are popping up everywhere.

National Cardiovascular Partners has been at the forefront of the movement toward safe and effective outpatient care for nearly a decade. Our skilled partner physicians and their dedicated staffs have performed well over 100,000 minimally invasive cardiovascular and endovascular procedures, including heart catheterizations, stent placements, and pacemaker insertions. In the hands of our experts, our patients enjoy extremely low complication and infection rates, and report extremely high overall satisfaction rates. How do we know? We meticulously track each and every procedural outcome, enabling us to share best practices throughout our organization and set the highest standards for the industry.

And in many ways, we are just getting started.

Earlier this year, the Centers for Medicare and Medicaid Studies (CMS) took an important step in updating the rules governing allowable payments in an outpatient setting by proposing a revision to their definition of “surgery” to include more codes outside the Current Procedural Terminology (CPT) surgical range. In addition, they also strongly signaled a willingness to include, in a future rulemaking, a number of the percutaneous coronary intervention procedures by specifically requesting feedback on these procedure codes. These procedures are currently only permissible in a hospital setting.

What does this mean? If approved, patients will no longer have to navigate a complicated and antiquated system and endure multiple procedures in multiple locations for safe and effective cardiovascular care. In other words, even more patients will be able to choose when, where, and how their procedures can be performed!

As both the national medical director for NCP and a practicing cardiologist for 20 years, I have seen firsthand how this outpatient movement has benefited and will continue to benefit our patients, from reduced costs to greater convenience and most importantly, better clinical results.

From a business perspective, the NCP model not only enables me to provide the highest quality of care to my patients without the administrative headaches that accompany a thriving practice, but also affords me greater flexibility with my schedule and a greater earning potential.

As technology continues to evolve and patients demand more say in their care, the outpatient trend is certain to continue. If you are interested in learning more about creating and growing your own hybrid ASC-Cath lab, with full clinical control and no administrative headaches, stop by our booth (#40G) at the upcoming Becker’s ASC Annual Meeting in Chicago on October 18–20, visit the NCP website, or give us a call (651) 846-8792 — we’d love to chat.

Pioneer of the Hybrid Cardiovascular Center Model Offers Physicians More Flexible Schedule and Joint Venture Opportunities

Neptune Beach, FL — MedAxiom, the nation’s leading cardiovascular healthcare membership organization and performance community, is excited to announce its corporate partnership with National Cardiovascular Partners (NCP), an organization working with physicians who want more professional control and freedom to provide high quality patient care through the hybrid cardiovascular center model.

“NCP is a national leader in ambulatory surgery center (ASC) and office based lab (OBL) design, development, and management,” said Joseph Sasson, Executive Vice President, MedAxiom Ventures. “As the outpatient strategy for cardiology will certainly see more of a shift to ASCs and OBLs in the coming years, we want to make sure that MedAxiom members are aware of the possibilities these locations of service offer and keep them up to date on the relevant regulations and coding changes in these settings. We are confident that MedAxiom’s partnership with NCP will help us to better meet the needs of our constituents in these areas.”

Since 2006, National Cardiovascular Partners has partnered with over 300 physicians and together they operate 23 outpatient Cardiovascular Centers in Texas, Arizona, Louisiana, Kansas, Florida and California, with a procedural mix that includes diagnostic catheterizations, peripheral interventions, vascular access procedures, PCI and AICD/pacemaker implantation. In 2014, NCP officially became part of Fresenius Medical Care North America, a multinational healthcare organization with a network of more than 2,400 dialysis facilities, vascular access centers and labs throughout the United States, Mexico and Canada.

“NCP is excited to enter into a corporate partnership with MedAxiom and share our outpatient success strategies with the cardiovascular community,” said Chad Ronis, Marketing and Communications Manager, NCP. “We are committed to the physicians’ priorities of outstanding clinical outcomes, efficient care and the growth of a business in an environment of collaboration.”

NCP’s physician partners performed over 17,000 procedures in our Cardiovascular Centers in 2017, with a patient satisfaction rate of 98.5%. These procedures included more than 3200+ pacemaker and defibrillator implants/ generator changes, nearly 7,000 cardiac catheterizations, 3,600+ peripheral interventions, and 7,500+ interventional cardiology cases. Labs are equipped with fixed Angio Suite C-arm equipment allowing providers to safely perform many of the same procedures completed in a hospital-based catheterization lab.

“I have had the opportunity to work with the National Cardiovascular Partners team since 2012,” said Denzil G. D’Souza, MD, FACC, FSCAI, Interventional & General Cardiology, Director, Heart & Vascular Center of Fort Worth, President & CEO, Fort Worth Heart, P.A. “They have been instrumental in planning, developing and managing the outpatient cardiovascular procedural center of which I am the director. I have found the NCP Team to be highly professional, effective and a pleasure to work with. They fully understand that the highest quality of care is the number one priority for physicians and support every measure to deliver the same to our patients. NCP’s understanding of the contractual and business aspects of outpatient cardiovascular procedural management is excellent and has been a real asset. Furthermore, NCP also provides a conduit and logistical support to interact with and be impactful on healthcare policy.”

MedAxiom members will have an opportunity to learn more about NCP at the CV Transforum Fall’18 conference, October 11-13, in Austin, TX, where they will be exhibiting.

About MedAxiom

MedAxiom is the nation’s leading cardiovascular performance community, providing expert consulting, networking and membership services including data analytics, program excellence tools and educational events. MedAxiom offers countless resources for all sectors of the cardiovascular health care industry and can connect its members, colleagues and the media with CV expertise to help advance the industry. The privately-held company was founded in 2001 by Jennifer Linville and is based in Neptune Beach, FL. For additional information, visit: http://www.medaxiom.com.

About NCP

National Cardiovascular Partners is part of Fresenius Medical Care North America, and partners with physicians to create, sustain and grow their independent ambulatory surgery center and catheterization lab. Their focus is hybrid surgery center and outpatient cardiac catheterization lab services in partnership with physician entrepreneurs. They created the hybrid ASC-Cath Lab model in 2006 and since then have built, acquired, grown, and optimized 23 outpatient surgery centers to operate at the highest and most efficient level.

Learn more about NCP at https://fmcna.com/national-cardiovascular-partners/

National Cardiovascular Partners and Columbus Vascular Vein & Wound Center Join Forces to Elevate Outpatient Vascular Care in Ohio

(Edina, MN.)  – National Cardiovascular Partners, LP (NCP), a leading nationwide developer, manager and operator of outpatient cardiovascular facilities, today announced a new joint venture partnership with Columbus Vascular Vein & Wound Center (CVVWC), central Ohio’s premier vascular and vein treatment practice.

This is NCP’s first joint venture partnership in Ohio.  As part of the deal, NCP will assume the daily management and operations of the vascular center, as well as credentialing, administrative and billing functions, freeing up the center’s physicians to focus exclusively on providing the highest quality of patient care. CVVWC will become part of the NCP’s network of 21 Outpatient Centers throughout the United States.

“We are thrilled to join forces with such an established and highly-respected company like NCP,” said Dr. Rajmony Pannu, owner and CEO of CVVWC. “Our priority has always been providing our patients with comprehensive and compassionate care.  NCP shares that vision, and together, we will take patient care to the next level.”

“We welcome CVVWC to our family of high-quality outpatient centers,” said Brian Gauger, President of NCP. “The combination of their tremendously talented team with our deep bench of experienced operators makes this the perfect partnership.”

With offices in Columbus, Zanesville and Newark, CVVWC’s team of highly trained physicians and medical staff specialize in treating all types of vascular disease in an office-based setting, reducing the need for complex open surgeries. The spectrum of treatment includes all aspects of peripheral arterial disease, critical limb ischemia,  non-healing wounds, swelling in the hands/legs/feet and chronic pain in the legs.  For more about the Vascular Center, please visit its website at https://cvvwc.com.

NCP is the pioneer of the Hybrid Cardiovascular Center model (POS11 /POS 24).  Services provided by NCP include assistance with physician partner recruitment, site selection, managed care contract negotiations and contracting, building design, financial arrangement, legal structuring and assistance with regulatory compliance, daily management of the facility, oversight of construction, monthly reporting to the facility’s governing board, equipment and supplies purchasing, and medical and management information systems, in addition to the recruitment, interviewing, and hiring of staff.  To learn more, please visit their website at www.ncplp.com.

Arizona Cardiovascular Institute & the Center for Cardiovascular Research and Education and Cardiovascular Consultants, Ltd. Join Nationwide Network of Outpatient Facilities

(Edina, MN) – National Cardiovascular Partners, LP (NCP), a leading nationwide developer, manager and operator of outpatient cardiovascular facilities, today announced a majority interest acquisition in two enterprises in Phoenix, Ariz. offering cardiac care, ambulatory surgery and catheterization lab services: The Arizona Cardiovascular Institute & the Center for Cardiovascular Research and Education (ACI/CCRE) and Cardiovascular Consultants, Ltd. (CVC), a cardiovascular practice group.

As part of the agreement, NCP will assume the daily management and operations of ACI/CCRE, as well as credentialing, and administrative and billing functions — freeing up the center’s physicians to focus exclusively on providing the highest quality of patient care. ACI/CCRE will become part of the NCP network of 24 outpatient centers throughout the United States.

“Joining the NCP team is of great value to us and provides the opportunity to better service our patients and community,” said Dr. Kishlay Anand, one of four physician partners at ACI/CCRE. “Our mission has always been to provide value to our patients by offering high quality and convenient outpatient care, and NCP not only shares this vision, but will help us elevate our services by allowing us to focus solely on operational excellence and ensuring the very best clinical outcomes.”

ACI/CCRE’s team of highly trained physicians and medical staff specialize in treating all types of cardiovascular disease in an outpatient Ambulatory Surgery Center (ASC) setting. The spectrum of treatments includes pacemaker and defibrillator implants/generator changes, cardiac catheterizations, peripheral interventions and varicose veins.

CVC was founded 32 years ago by Dr. Andrei Damian and has nine locations with 25 physicians and 200 staff members, serving the greater Phoenix Metropolitan area. CVC’s team of highly trained physicians and medical staff cover the spectrum of cardiac services and are dedicated to meeting the needs of their patients and assisting them with living a healthful and productive life.

“We are pleased to become part of the NCP team,” said Dr. Andrei Damian, President & CEO of CVC. “As our healthcare landscape continues to evolve, it is essential that medical practices provide patients with the highest quality, most convenient and efficient cardiovascular care available.  We are happy to join forces with a partner who shares our vision and commitment to clinical excellence and patient satisfaction.”

“We welcome ACI/CCRE and CVC to our family of high-quality cardiology centers,” said Brian Gauger, President & CEO of NCP. “We are dedicated to supporting our physician partners so that they can focus 100 percent of their energy and effort on providing the very best and most clinically advanced care to their patients.”

Huron Transaction Advisory, LLC (HTA), Huron’s investment bank, served as exclusive financial advisor to CVC and ACI/CCRE in connection with the recapitalizations.

For more about ACI/CCRE, please visit its website at https://azcardiovascular.com/.

For more information about the CVC, please visit its website at http://cvcheart.com/.

For more information about Huron Transaction Advisory, LLC, please visit its website at http://huronconsultinggroup.com.

About National Cardiovascular Partners

National Cardiovascular Partners, a division of Fresenius Medical Care North America, partners with physicians to create, sustain and grow independent ambulatory surgery centers and catheterization labs. Their focus is on hybrid surgery center and outpatient cardiac catheterization lab services, in partnership with physician entrepreneurs. NCP currently operates 24 surgery centers throughout the US. To learn more, please visit www.ncplp.com.

About Fresenius Medical Care North America

Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.

National Cardiovascular Partners and Mesa Cardiovascular Research Center Join Forces to Elevate Outpatient Cardiovascular Care in Arizona

(Edina, MN.)  – National Cardiovascular Partners, LP (NCP), a leading nationwide developer, manager and operator of outpatient cardiovascular facilities, today announced a new joint venture partnership with Mesa Cardiovascular Research Center, an outpatient cardiovascular center in Mesa, AZ.

This is NCP’s fourth joint venture partnership in Arizona. As part of the deal, NCP will assume the daily management and operations of the cardiovascular center, as well as credentialing, administrative and billing functions, freeing up the center’s physicians to focus exclusively on providing the highest quality of patient care. Mesa Cardiovascular Research Center will become part of NCP’s network of 25 Outpatient Centers throughout the United States.

“NCP will be a tremendous corporate partner in the center and allow us to solely focus on patient quality and care,” said Dr. Andrew Kaplan, a physician partner with Mesa Cardiovascular Research Center. “NCP shares our vision of excellent and efficient cardiovascular care, and together, we will take patient care to the next level.” This new joint venture partnership was formed with NCP with a vision of combining years of clinical experience with years of corporate experience. Both Dr. Kaplan and his partner, Dr. Al Ambrosia, bring more than 40 years’ experience in Electrophysiology and Interventional Cardiology. The physicians will be performing device implants and ablations, as well as peripheral vascular arterial and venous procedures, coronary, carotid and renal artery procedures.

“We are excited to have Mesa Cardiovascular Research Center as part of our family of high-quality outpatient centers,” said Brian Gauger, President & CEO of NCP. “The combination of their cardiovascular procedures and clinical research, along with our business expertise makes this the perfect partnership.”

About Mesa Cardiovascular Research Center

Mesa Cardiovascular Research Center’s team of highly trained physicians and medical staff specialize in treating all types of cardiovascular disease in an outpatient setting, reducing the need for complex open surgeries. For more about the cardiovascular center, please visit its website at https://mesacardiovascular.com.

About National Cardiovascular Partners

National Cardiovascular Partners, a division of Fresenius Medical Care North America, partners with physicians to create, sustain and grow independent ambulatory surgery centers and catheterization labs. Their focus is on hybrid surgery center and outpatient cardiac catheterization lab services, in partnership with physician entrepreneurs. NCP currently operates 24 surgery centers throughout the US. To learn more, please visit www.ncplp.com.

About Fresenius Medical Care North America

Fresenius Medical Care North America is the premier health care company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated health care services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.